Latest News about EDIT
Recent news which mentions EDIT
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
September 10, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
September 10, 2021
From Benzinga
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
August 31, 2021
From Motley Fool
The 3 Best Biotech Stocks to Buy Right Now
August 27, 2021
From Motley Fool
60 Biggest Movers From Yesterday
August 24, 2021
From Benzinga
From InvestorPlace
35 Stocks Moving In Monday's Mid-Day Session
August 23, 2021
From Benzinga
25 Stocks Moving in Monday's Pre-Market Session
August 23, 2021
From Benzinga
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
August 09, 2021
From Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
From Benzinga
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
August 05, 2021
From Benzinga
10 Biggest Price Target Changes For Thursday
August 05, 2021
From Benzinga
Editas Medicine, inc (EDIT) Q2 2021 Earnings Call Transcript
August 04, 2021
Tickers
EDIT
From Motley Fool
From Motley Fool
From InvestorPlace
From InvestorPlace
From Motley Fool
From InvestorPlace
Tickers
EDIT
From InvestorPlace
From Motley Fool
From Motley Fool
From Benzinga
The Top 3 Gene Editing Stocks to Own for the Next Decade
July 12, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.